FIELD: medicine.
SUBSTANCE: agent contains riboflavin riboflavin mononucleotide and dextran in the following proportions, wt %: riboflavin mononucleotide 1.0; dextran 20.0; normal saline - the rest.
EFFECT: forming the stable pre-corneal sustained-action colouring film, additional therapeutic activity of active substances and additives.
3 ex
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMOLOGICAL MEANS FOR CORNEAL INJURIES AND DISEASES DIAGNOSTICS | 2016 |
|
RU2633083C1 |
PREPARATION FOR DIAGNOSIS OF EYE CORNEA ILLNESS AND TRAUMA | 1995 |
|
RU2098089C1 |
PREPARATION FOR EYE CORNEA ILLNESS AND TRAUMA DIAGNOSIS | 1995 |
|
RU2097031C1 |
PREPARATION FOR DIAGNOSIS OF DISEASES AND TRAUMAS OF EYE CORNEA | 1995 |
|
RU2142292C1 |
PREPARATION FOR DIAGNOSTICS OF EYE CORNEA INJURY | 2009 |
|
RU2404811C1 |
OPHTHALMOLOGICAL MEANS FOR ULTRAVIOLET CORNEAL CROSSLINKING | 2016 |
|
RU2646452C1 |
HYPOSMOTIC OPHTHALMIC MEANS FOR ULTRAVIOLET CROSSLINKING OF THIN CORNEAS | 2016 |
|
RU2631604C1 |
OPHTHALMIC AGENT FOR TRANSEPITHELIAL ULTRAVIOLET CORNEAL COLLAGEN CROSSLINKING | 2014 |
|
RU2560669C1 |
METHOD FOR APPLICATION OF REMEDY OIL SOLUTION ON CORNEA | 0 |
|
SU1771734A1 |
CROSS-LINKING OPHTHALMIC AGENT | 2009 |
|
RU2412707C1 |
Authors
Dates
2015-06-10—Published
2014-03-25—Filed